Navigation Links
Circassia Announces Acquisition of Organ Transplant Anti-Rejection Technology

Circassia Ltd, a specialty biopharmaceutical company focused on controlling immune system responses, announced the acquisition of a novel anti-rejection technology for use in organ transplantation.

Circassia acquired the proprietary technology, known as ToleroTrans, from The University of Birmingham in the UK for an undisclosed upfront sum, plus future milestone payments and royalties on product sales. Scientifically, the ToleroTrans approach mirrors that of Circassia's existing anti-allergy technology, by utilising T-cell epitopes to down-regulate patients' unwanted immune responses.

"The acquisition of the ToleroTrans anti-rejection technology provides us with a unique opportunity to expand our pipeline of next generation immune control medicines," said Steve Harris, Circassia's CEO. "Our current anti-allergy technology works via a very similar mechanism, meaning ToleroTrans fits perfectly within our scientific focus. I am delighted that we have completed this acquisition so soon after establishing Circassia earlier this year, and believe it will prove an important step in building a broad, world-class immune control company."

Organ transplantation is a complex medical undertaking, which requires careful tissue type matching between the donor and recipient to reduce the risk of rejection. Organ rejection can occur when the recipient's immune system reacts strongly to protein molecules, termed antigens, present on the cells of the donated organ. The ToleroTrans technology employs specific small portions of antigen molecules, called T-cell epitopes. Scientists then test these epitopes, utilising blood samples from patients awaiting organ transplantation, to determine which have the potential to desensitize the recipient's immune system, and thereby reduce the risk of rejection.


'"/>




Page: 1

Related medicine news :

1. Ramdoss Announces Introduction of RCH-II
2. Britain Announces Third Transfusion Related Mad Cow Case
3. Tibet Announces the Dalai Lama’s Tour of South Americ
4. Indian PM Announces Of Setting Up India Study Center At Tashkent
5. PowderMed Announces Needle-Less Flu Vaccine
6. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Australian Government Announces Survey To Tackle Childhood Obesity
9. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
10. Apollo Announces Research on Indian Cardiac Epidemic
11. Government Announces Steps To Promote Ayurvedic Medicine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/25/2017)... ... ... Swissray is pleased to announce the release of the ELITE DXA, a new bone ... scan window, which is more than double that of existing bone densitometers. Historically, subjects ... an accurate total body bone density or body composition study. The ELITE DXA ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... at the same time by providing Prehospital Trauma Life Support (PHTLS) course scholarships ... world’s premier prehospital trauma education developed in cooperation with the American College of ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... from third world countries to hospitals in the United States, it’s a threat ... on the current obstacles facing infection prevention and offers strategies for the healthcare ...
(Date:3/24/2017)... ... , ... The Radiology Business Management Association (RBMA) has named the ... their 12th year, are among the most prestigious in radiology marketing because a panel ... retooled to recognize achievements in both large budget (over $5,000) and small budget (under ...
(Date:3/24/2017)... ... March 24, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is ... 9618 Huebner Road. The clinic is the group’s 7th location in San Antonio and ... Higgins, PT, will provide care from the clinic, which opened March 22, 2017. ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017  Zymo Research Corp., also known ... Inc., who designs, manufactures and distributes liquid ... teams Zymo Research,s DNA methylation detection and ... products with Hamilton,s high-throughput automation platforms. Zymo ... microbiomics and RNA isolation for use on ...
(Date:3/24/2017)... , March 24, 2017   The ... organization within medical affairs in the pharmaceutical industry ... the chair of a newly formed scientific advisory ... members to form the first ever medical affairs ... For more information about the ACMA, please visit  ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research and ... (IPF) Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with ... Corporation, Merck & Co., Inc., Biogen and Sanofi are involved in the ... candidates, of which one is in Phase III stage, 15 are in ...
Breaking Medicine Technology: